Welcome to CDC stacks | CDC : 40 years of prevention - 21421 | David J. Sencer CDC Museum
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Previous Button
Previous Button
CDC : 40 years of prevention
Record #: 86 of 86
  • Published Date:
    June 1986
  • Source:
    Dateline: CDC ; v. 18, no. 5, rev.
  • Series:
    Dateline: CDC
  • Language:
    English
Filetype[PDF-7.60 MB]


This document cannot be previewed automatically as it exceeds 5 MB
Please click the thumbnail image to view the document.
CDC : 40 years of prevention
Details:
  • Supporting Files:
    No Additional Files
No Related Documents.
You May Also Like:
  1. GRADE Hepatitis A vaccine for post-exposure prophylaxis in adults >40 years of age
    Personal Author:
    Nelson, Noele
    Corporate Author:
    National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). United States. Advisory Committee on Immunization Practices. Hepatitis Vaccines Work Group..
    Conference Author:
    United States. Advisory Committee on Immunization Practices. Meeting (2018 February 21-22 : Atlanta, GA)
    Published:
    3/26/18
    Series:
    ACIP meeting Hepatitis Vaccines
    Description:
    Presentations February 2018 Day 1 : Publication date from document properties. : Hepatitis-04-Nelson-508.pdf
    File Type:
    Filetype[PDF - 464.63 KB]
  2. Colonoscopy Screening Among US Adults Aged 40 or Older With a Family History of Colorectal Cancer
    Personal Author:
    Tsai, Meng-Han; Xirasagar, Sudha; Li, Yi-Jhen; de Groen, Piet C.;
    Published:
    May 21 2015
    Source:
    Prev Chronic Dis. 12.
    Description:
    Introduction : Colonoscopy screening reduces colorectal cancer (CRC) incidence and mortality. CRC screening is recommended at age 50 for average-risk people. Screening of first-degree relatives of CRC patients is recommended to begin at age 40 or 10 ...
    File Type:
    Filetype[PDF - 304.80 KB]
  3. Update on recommendations for use of herpes zoster vaccine
    Personal Author:
    Hales, Craig M.; Harpaz, Rafael; Ortega-Sanchez, Ismael; Bialek, Stephanie R.;
    Corporate Author:
    United States. Advisory Committee on Immunization Practices.. National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases..
    Published:
    August 22, 2014
    Series:
    MMWR. Morbidity and mortality weekly report, Vol. 63, no. 33, p. 729-31
    Description:
    Herpes zoster vaccine (Zostavax [Merck & Co., Inc.]) was licensed in 2006 and recommended by the Advisory Committee on Immunization Practices (ACIP) in 2008 for prevention of herpes zoster (shingles) and its complications among adults aged ≥60 year...
    Status:
    current
    File Type:
    Filetype[PDF - 195.85 KB]
  4. Update on Recommendations for Use of Herpes Zoster Vaccine
    Personal Author:
    Hales, Craig M.; Harpaz, Rafael; Ortega-Sanchez, Ismael; Bialek, Stephanie R.;
    Corporate Author:
    United States. Advisory Committee on Immunization Practices.
    Published:
    Aug 22 2014
    Source:
    MMWR Morb Mortal Wkly Rep. 2014; 63(33):729-731.
    Description:
    Herpes zoster vaccine (Zostavax [Merck & Co., Inc.]) was licensed in 2006 and recommended by the Advisory Committee on Immunization Practices (ACIP) in 2008 for prevention of herpes zoster (shingles) and its complications among adults aged ≥60 year...
    File Type:
    Filetype[PDF - 109.32 KB]
  5. Percentage of Deaths Associated With Inadequate Physical Activity in the United States
    Personal Author:
    Carlson, Susan A.; Adams, E. Kathleen; Yang, Zhou; Fulton, Janet E.;
    Published:
    Mar 29 2018
    Source:
    Prev Chronic Dis. 15.
    Description:
    Introduction : Current physical activity guidelines recommend that adults participate weekly in at least 150 minutes of moderate-intensity equivalent aerobic physical activity to achieve substantial health benefits. We used a nationally representativ...
    File Type:
    Filetype[PDF - 407.25 KB]